Loss of LYN Is Frequent in Targeted Therapy–Resistant Melanoma Cells and Favors Metastatic Properties
Céline Gaudel(Inserm), Robert Ballotti(La Ligue Contre le Cancer)
Cited by 0
Related Papers
Up-regulation of MET Expression by α-Melanocyte-stimulating Hormone and MITF Allows Hepatocyte Growth Factor to Protect Melanocytes and Melanoma Cells from Apoptosis
|Journal of Biological Chemistry|2007|82
FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells
|Cell Death and Differentiation|2021|34
Regulation of Melanogenesis by the Amino Acid Transporter SLC7A5
|Journal of Investigative Dermatology|2020|17